EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Convergent and Divergent Mitochondrial Pathways as Causal Drivers and Therapeutic Targets in Neurological Disorders

Yanan Du, Sha-Sha Fan, Hao Wu, Junwen He, Yang He, Xiang-Yu Meng iD, Xuan Xu iD

Current Issues in Molecular Biology · 08.08.2025 · 47 (8) · 636

DOI: 10.3390/cimb47080636 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 08.08.2025. Verfasst von Yanan Du und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Anhui Medical University, Hefei 230032, China. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Research Fund for the Doctoral Program of Anhui Medical University, National Natural Science Foundation of China, Natural Science Foundation of Hubei Province of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mitochondrial dysfunction is implicated across a spectrum of neurological diseases, yet its causal role and mechanistic specificity remain unclear. This study employed a multi-modal integrative analysis of mitochondrial gene expression in Alzheimer’s Disease (AD), Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Parkinson’s Disease (PD) to address these gaps. We combined machine learning for predictive modeling with genetic causal inference methods (Mendelian Randomization, colocalization, PheWAS), followed by drug enrichment analysis and molecular docking. Our machine learning models, particularly Support Vector Machine and Multi-layer Perceptron, effectively classified these conditions, with MS exhibiting the highest predictability (mean Accuracy: 0.758). Causal inference analyses identified specific gene–disease links; for instance, genetically predicted increased expression of PDK1 was causally associated with an elevated risk for both AD (OR = 1.041) and ALS (OR = 1.037), identifying pyruvate metabolism as a shared vulnerability. In contrast, genes like SLC25A38 emerged as highly predictive specifically for PD. We also observed evidence of potential brain–periphery interaction, such as a bidirectional causal relationship between red blood cell indices and MS risk. Finally, drug enrichment analysis highlighted Celecoxib, and subsequent molecular docking predicted a strong binding affinity to PDK1 (docking score S = −6.522 kcal/mol), generating hypotheses for potential metabolic modulation. Taken together, this study provides a computational hypothesis framework suggesting mitochondrial pathways and targets that warrant future biological validation. This study provides specific, genetically supported evidence for the causal role of mitochondrial pathways in neurological diseases and identifies tangible targets for future therapeutic development.

Schlagwörter

Stichwörter der Autor:innen

Alzheimer’s diseaseMendelian randomizationdrug repurposingmachine learningmitochondrianeurological diseases

Autor:innen und Institutionen

  • School of Life Sciences, Anhui Medical University, Hefei 230032, China.
  • School of Health Management, Anhui Medical University, Hefei 230032, China.
  • Health Science Center, Medical School, Hubei Minzu University, Enshi 445000, China.
  • College of Informatics, Huazhong Agricultural University, Wuhan 430070, China.

ORCID-Profile: Xiang-Yu Meng, Xuan Xu

Förderung

  • the Research Fund for the Doctoral Program of Anhui Medical University
  • National Natural Science Foundation of China
  • Natural Science Foundation of Hubei Province of China
  • “Chutian Scholars Program” of Hubei Province of China

Zitieren

APA

Du, Y., Fan, S. S., Wu, H., He, J., He, Y., Meng, X. Y., & Xu, X. (2025). Convergent and Divergent Mitochondrial Pathways as Causal Drivers and Therapeutic Targets in Neurological Disorders. Current Issues in Molecular Biology, 47(8), 636. https://doi.org/10.3390/cimb47080636

Vancouver

Du Y, Fan SS, Wu H, He J, He Y, Meng XY, et al. Convergent and Divergent Mitochondrial Pathways as Causal Drivers and Therapeutic Targets in Neurological Disorders. Current Issues in Molecular Biology. 2025;47(8):636. doi:10.3390/cimb47080636

BibTeX
@article{Du2025,
  author = {Du, Yanan and Fan, Sha-Sha and Wu, Hao and He, Junwen and He, Yang and Meng, Xiang-Yu and Xu, Xuan},
  title = {Convergent and Divergent Mitochondrial Pathways as Causal Drivers and Therapeutic Targets in Neurological Disorders},
  journal = {Current Issues in Molecular Biology},
  year = {2025},
  volume = {47},
  number = {8},
  pages = {636},
  doi = {10.3390/cimb47080636}
}
Kostenlos starten →